Rang	Name	Position
1	Mr. Thomas W. Eastling M.D.	Chief Financial Officer
2	Mr. Weiguo Ye	Chief Operating Officer
3	Ms. Ruoyu Chen	Chief Information Officer
4	Dr. Ying Luo Ph.D.	CEO, President & Director
5	Dr. Yue Xiong Ph.D.	Chief Scientific Officer & Director
6	Mr. Joshua Bergmann J.D.	General Counsel & Corporate Secretary
7	Seth Goldblum M.B.A.	Senior Vice President of Corporate Development
8	Mr. Jialiang Wang Ph.D.	Executive VP & GM
9	Jing Liu Ph.D.	Senior Vice President of Platform Chemistry
10	Mark Marino	Senior Vice President of Clinical Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Capital Management, LLC	0,93%	6,62 Mio. USD
2	Octagon Capital Advisors LP	0,90%	6,42 Mio. USD
3	BlackRock Inc	0,72%	5,11 Mio. USD
4	Geode Capital Management, LLC	0,41%	2,90 Mio. USD
5	State Street Corp	0,20%	1,46 Mio. USD
6	SBI Securities Co Ltd	0,16%	1,15 Mio. USD
7	Charles Schwab Investment Management Inc	0,16%	1,11 Mio. USD
8	Vanguard Fiduciary Trust Co	0,13%	0,93 Mio. USD
9	Northern Trust Corp	0,13%	0,90 Mio. USD
10	The Goldman Sachs Group Inc	0,07%	0,49 Mio. USD
11	Vanguard Portfolio Management, LLC	0,07%	0,47 Mio. USD
12	Bank of New York Mellon Corp	0,04%	0,29 Mio. USD
13	Dimensional Fund Advisors, Inc.	0,02%	0,17 Mio. USD
14	AllianceBernstein L.P.	0,02%	0,15 Mio. USD
15	STRS OHIO	0,02%	0,14 Mio. USD
16	UBS Group AG	0,02%	0,14 Mio. USD
17	FMR Inc	0,02%	0,13 Mio. USD
18	Millennium Management LLC	0,02%	0,12 Mio. USD
19	Brevan Howard Capital Management LP	0,01%	0,09 Mio. USD
20	Rhumbline Advisers	0,01%	0,09 Mio. USD